This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Efficacy of Molindone in Treatment-Refractory Agitated Schizophrenia: Three Case Reports

Michael Ciranni, PhD; Jean-Pierre Lindenmayer, MD; and Jeffrey Goldx, MD

Published: June 30, 2008

Article Abstract

Letter to the Editor

Sir: Agitated behavior of schizophrenic patients refractoryto antipsychotic treatment frequently leads to prolonged psychiatricinpatient stays. Difficulty in controlling such behaviorscan impede discharge planning more than any other aspect ofschizophrenia (e.g., negative symptoms). Treatments that canreduce persistent agitation are thus a key component of helpingpatients leave the hospital and function in the community.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...